Jasmine Kway
CIK: 0001808135
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
VOLITIONRX LTD
Discretionary Trading P&L
Holdings
Transaction History (9 total)
- Feb 26, 2026VNRX
VOLITIONRX LTD
Award(A)Direct173K shares- - Jan 22, 2026VNRX
VOLITIONRX LTD
Award(A)Direct42K shares- - Aug 15, 2025VNRX
VOLITIONRX LTD
Award(A)Direct12.5K shares- - Jun 1, 2025VNRX
VOLITIONRX LTD
Award(A)Direct8.3K shares- - Mar 1, 2025VNRX
VOLITIONRX LTD
Award(A)Direct16.7K shares- - Jan 29, 2025VNRX
VOLITIONRX LTD
Award(A)DirectStock Option (Right to Buy)
50K shares- - Jan 29, 2025VNRX
VOLITIONRX LTD
Disposition(D)DirectStock Option (Right to Buy)
50K shares- - Dec 1, 2024VNRX
VOLITIONRX LTD
Award(A)Direct15.2K shares- - Sep 1, 2024VNRX
VOLITIONRX LTD
Award(A)Direct15.7K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Feb 26, 2026 | VNRX VOLITIONRX LTD | Award(A) | 173,000 | - | $0 | Direct |
| Jan 22, 2026 | VNRX VOLITIONRX LTD | Award(A) | 42,000 | - | $0 | Direct |
| Aug 15, 2025 | VNRX VOLITIONRX LTD | Award(A) | 12,507 | - | - | Direct |
| Jun 1, 2025 | VNRX VOLITIONRX LTD | Award(A) | 8,327 | - | - | Direct |
| Mar 1, 2025 | VNRX VOLITIONRX LTD | Award(A) | 16,708 | - | - | Direct |
| Jan 29, 2025 | VNRX VOLITIONRX LTD | Award(A) Stock Option (Right to Buy) | 50,000 | - | - | Direct |
| Jan 29, 2025 | VNRX VOLITIONRX LTD | Disposition(D) Stock Option (Right to Buy) | 50,000 | - | - | Direct |
| Dec 1, 2024 | VNRX VOLITIONRX LTD | Award(A) | 15,169 | - | $0 | Direct |
| Sep 1, 2024 | VNRX VOLITIONRX LTD | Award(A) | 15,668 | - | $0 | Direct |
1-9 of 9 transactions
About Kway Jasmine
Kway Jasmine (SEC CIK 0001808135) files insider reports with the SEC as CEO - Singapore Volition of VOLITIONRX LTD (VNRX).
Signal8 holds 8 ownership filings by Kway Jasmine, all Form 4s, filed between Sep 4, 2024 and Feb 27, 2026. Those filings report 9 transactions, from Sep 1, 2024 to Feb 26, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Kway Jasmine's filings is in HENDERSON, NV.
Recent filings by Kway Jasmine
- Feb 26, 2026: Grant or award of VNRX shares (Form 4, code A).
- Jan 22, 2026: Grant or award of VNRX shares (Form 4, code A).
- Aug 15, 2025: Grant or award of VNRX shares (Form 4, code A).
- Jun 1, 2025: Grant or award of VNRX shares (Form 4, code A).
- Mar 1, 2025: Grant or award of VNRX shares (Form 4, code A).
Other insiders filing for VOLITIONRX LTD (VNRX)
- Batchelor Ann-Louise, Group Chief Marketing Officer
- Forterre Gael, Chief Commercial Officer
- Rootsaert Rodney Gerard, Secretary
- Micallef Jacob Vincent, Chief Scientific Officer
- Plummer Nicholas, GC - Volition Diagnostics
- Rubin Ethel, Director